Growth Metrics

Aspen Aerogels (ASPN) Equity Average (2016 - 2025)

Aspen Aerogels' Equity Average history spans 12 years, with the latest figure at $270.6 million for Q4 2025.

  • For the quarter ending Q4 2025, Equity Average fell 51.78% year-over-year to $270.6 million, compared with a TTM value of $270.6 million through Dec 2025, down 51.78%, and an annual FY2025 reading of $425.1 million, down 22.9% over the prior year.
  • Equity Average for Q4 2025 was $270.6 million at Aspen Aerogels, down from $307.3 million in the prior quarter.
  • The five-year high for Equity Average was $561.2 million in Q4 2024, with the low at $67.2 million in Q1 2021.
  • Average Equity Average over 5 years is $321.2 million, with a median of $313.4 million recorded in 2022.
  • Year-over-year, Equity Average soared 183.85% in 2023 and then plummeted 51.78% in 2025.
  • Tracing ASPN's Equity Average over 5 years: stood at $135.4 million in 2021, then surged by 132.53% to $314.9 million in 2022, then soared by 42.55% to $448.9 million in 2023, then rose by 25.0% to $561.2 million in 2024, then crashed by 51.78% to $270.6 million in 2025.
  • Per Business Quant, the three most recent readings for ASPN's Equity Average are $270.6 million (Q4 2025), $307.3 million (Q3 2025), and $311.8 million (Q2 2025).